Cargando…

The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

BACKGROUND: Rhabdoid tumors are highly aggressive malignancies affecting infants and very young children. In many instances these tumors are resistant to conventional type chemotherapy necessitating alternative approaches. METHODS: Proliferation assays (MTT), apoptosis (propidium iodide/annexin V) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerl, Kornelius, Ries, David, Unland, Rebecca, Borchert, Christiane, Moreno, Natalia, Hasselblatt, Martin, Jürgens, Heribert, Kool, Marcel, Görlich, Dennis, Eveslage, Maria, Jung, Manfred, Meisterernst, Michael, Frühwald, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693872/ https://www.ncbi.nlm.nih.gov/pubmed/23764045 http://dx.doi.org/10.1186/1471-2407-13-286

Ejemplares similares

Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
por: Moreno, Natalia, et al.
Publicado: (2017)

BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
por: Krämer, Katja F., et al.
Publicado: (2017)

Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
por: Blümel, Lena, et al.
Publicado: (2022)

Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors
por: Graf, Monika, et al.
Publicado: (2022)

ATRT-13. DIFFERENT CELLS OF ORIGIN PAVE THE WAY FOR MOLECULAR HETEROGENEITY IN RHABDOID TUMORS
por: Graf, Monika, et al.
Publicado: (2020)

Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
por: Ho, Ben, et al.
Publicado: (2020)

Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
por: Ho, Ben, et al.
Publicado: (2020)

Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
por: Zin, Francesca, et al.
Publicado: (2021)

Improved 6‐year overall survival in AT/RT – results of the registry study Rhabdoid 2007
por: Bartelheim, Kerstin, et al.
Publicado: (2016)

ATRT-05. Infants and newborns with atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors: a unique and challenging population
por: Nemes, Karolina, et al.
Publicado: (2022)

Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
por: Chun, Hye-Jung E., et al.
Publicado: (2019)

Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population
por: Nemes, Karolina, et al.
Publicado: (2022)

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
por: Paassen, Irene, et al.
Publicado: (2023)

Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration
por: Wolf, Ines M. L., et al.
Publicado: (2014)

Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells
por: Grabarska, Aneta, et al.
Publicado: (2017)

Histone Deacetylase Inhibitor (SAHA) Reduces Mortality in an Endotoxemia Mouse Model by Suppressing Glycolysis
por: Wu, Yunchen, et al.
Publicado: (2023)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
por: Tambunan, Usman SF, et al.
Publicado: (2011)

Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics
por: Johann, Pascal D., et al.
Publicado: (2023)

Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
por: Nemes, Karolina, et al.
Publicado: (2022)

Cladribine Induces ATF4 Mediated Apoptosis and Synergizes with SAHA in Diffuse Large B-Cell Lymphoma Cells
por: Xu, Linyan, et al.
Publicado: (2020)

Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics
por: Huang, Huichao, et al.
Publicado: (2020)

Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
por: Pathak, Rajiv, et al.
Publicado: (2021)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

Fenretinide: A Novel Treatment for Endometrial Cancer
por: Mittal, Navdha, et al.
Publicado: (2014)

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes
por: Bocchi, Leonardo, et al.
Publicado: (2019)

Synergistic Radiosensitization by Gold Nanoparticles and the Histone Deacetylase Inhibitor SAHA in 2D and 3D Cancer Cell Cultures
por: Igaz, Nóra, et al.
Publicado: (2020)

Professor Kshitish Chandra Saha
por: Coondoo, Arijit
Publicado: (2016)

First person – Santu Saha
Publicado: (2023)

Phosphorus containing analogues of SAHA as inhibitors of HDACs
por: Pun, Michael D., et al.
Publicado: (2022)

Primary rhabdoid tumor of the ovary: When large cells become small cells
por: Rabinovich, Alex, et al.
Publicado: (2015)

Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity
por: Meng, Jia, et al.
Publicado: (2014)

Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques
por: Ling, Binhua, et al.
Publicado: (2014)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells
por: Zhou, Qiong, et al.
Publicado: (2011)

Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
por: Yang, H, et al.
Publicado: (2015)

Histone Deacetylase Inhibitor SAHA Improves High Salinity Tolerance Associated with Hyperacetylation-Enhancing Expression of Ion Homeostasis-Related Genes in Cotton
por: He, Shibin, et al.
Publicado: (2020)

ATRT-13. An integrative analysis of the ATRT proteome unravels novel drug targets and refines molecular subgrouping
por: Johann, Pascal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s9npnair60qopu6b94s12dti6n